Dual non-responsiveness to antiplatelet treatment is a stronger predictor of cardiac adverse events than isolated non-responsiveness to clopidogrel or aspirin (Q46782610)
Jump to navigation
Jump to search
scientific article published on 2 February 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dual non-responsiveness to antiplatelet treatment is a stronger predictor of cardiac adverse events than isolated non-responsiveness to clopidogrel or aspirin |
scientific article published on 2 February 2012 |
Statements
1 reference
Dual non-responsiveness to antiplatelet treatment is a stronger predictor of cardiac adverse events than isolated non-responsiveness to clopidogrel or aspirin (English)
1 reference
1 reference
Bernd Jilma
1 reference
Georg Delle-Karth
1 reference
Günter Christ
1 reference
Thomas Neunteufl
1 reference
Kurt Huber
1 reference
Alexander Tolios
1 reference
Christa Drucker
1 reference
2 February 2012
1 reference
167
1 reference
430-435
1 reference
2
1 reference
Identifiers
1 reference
1 reference